Related Experiment Videos
Immune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane
1Department of Experimental Immunobiology, Wellcome Biotech, Beckenham, Kent, United Kingdom.
Abstract:
Noncovalent complexes of meningococcal group B polysaccharide and outer membrane proteins (OMPs) from serotypes 2a, 2b, 6, 8, and 15 were made either by coextraction of the two components from culture supernatants or by separate preparation of both OMPs and B polysaccharide with subsequent mixing of the two components. The former method showed a markedly greater degree of binding of B polysaccharide to OMPs, a less heterogeneous composition of OMPs, and a lower lipopolysaccharide content. Immunization of mice with these complexes showed that a higher degree of binding of B polysaccharide to OMPs resulted in a higher anti-B response. Western blotting (immunoblotting) and solid-phase radioimmunoassay techniques confirmed that antibody cross-reactions occur among OMP serotypes. The occurrence of common T-cell determinants between OMP serotypes was suggested when mice primed with a type 6 OMP complex and challenged with a homologous or heterologous serotype complex responded with significantly higher anti-B titers than unprimed animals. These memory T cells persisted for at least 12 months in mice.
Insights
Creating meningococcal group B polysaccharide and outer membrane protein (OMP) complexes enhances anti-B immune responses in mice. Higher polysaccharide binding to OMPs correlates with a stronger antibody response, indicating potential for improved vaccine development.
Area of Science:
- Immunology
- Microbiology
- Vaccine Development
Background:
- Neisseria meningitidis serogroup B (MenB) poses a significant public health challenge.
- Developing effective vaccines against MenB requires understanding antigen presentation and immune response.
- Outer membrane proteins (OMPs) and polysaccharides are key components of MenB.
Purpose of the Study:
- To investigate the formation and immunogenicity of noncovalent complexes between meningococcal group B polysaccharide and OMPs.
- To evaluate the impact of polysaccharide-OMP binding efficiency on the anti-B immune response.
- To explore cross-reactivity and T-cell determinant sharing among different OMP serotypes.
Main Methods:
- Coextraction and separate preparation methods were used to create polysaccharide-OMP complexes.
- Immunization of mice with these complexes.
- Western blotting (immunoblotting) and solid-phase radioimmunoassay for antibody detection.
- Analysis of anti-B antibody titers and T-cell responses.
Main Results:
- Coextraction yielded complexes with higher polysaccharide binding, less OMP heterogeneity, and lower lipopolysaccharide content.
- Increased polysaccharide-OMP binding correlated with a higher anti-B antibody response in mice.
- Antibody cross-reactions were observed among different OMP serotypes.
- Evidence suggests common T-cell determinants across OMP serotypes, inducing robust secondary responses.
Conclusions:
- The method of complex formation significantly impacts OMP composition and polysaccharide binding.
- Enhanced polysaccharide-OMP binding promotes a stronger anti-group B immune response.
- Shared T-cell determinants among OMP serotypes offer a promising avenue for broad-spectrum MenB vaccine strategies.
- Long-lasting T-cell memory was observed, suggesting durable immune protection.